drugset
drugset / Trial / NCT00498303

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

NCT00498303 ↗

Phase 3 Completed 120 enrolled Novartis Novartis Vaccines · collab
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Annual trial for registration of trivalent split influenza vaccine with the strain composition of the season 2007/2008 in healthy adult and elderly subjects

Timeline

Start
2007-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject trivalent split influenza vaccine Vaccine — —

Indications

influenza